Male Infertility:Based on findings in animals, OPSUMIT®may impair fertility in males of reproductive potential. Pediatric Use The safety and efficacy of OPSUMIT®in children have not been established. Please read accompanying fullPrescribing Information, including BOXED WARNING, for OPSUMIT®. ...
KANUMA is administered as an intravenous infusion under the supervision of a healthcare professional.1 For more information, download the full Prescribing Information and Dosing and Administration brochure below: Download Full Prescribing Information Getting Started on Kanuma® (sebelipase alfa) KANUMA...
On theHCPLivenews page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development. ...
Generalized polyneuropathyhas been reported in patients receiving DUOPA. Assess patients for the signs and symptoms of peripheral neuropathy before and periodically after starting DUOPA, especially patients with pre-existing neuropathy, patients taking medications, or those who have medical conditions associate...
No dosage adjustment is necessary in patients with mild renal impairment. Because of an increase in the exposure of a major metabolite, use of VUMERITY is not recommended in patients with moderate or severe renal impairment Please see full Prescribing Information.INDICATION...
Please seeaccompanyingfullPrescribing Information Indications Atopic Dermatitis:DUPIXENT is indicated for the treatment of adult and pediatric patients aged 6 months and older with moderate-to-severe atopic dermatitis (AD) whose disease is not adequately controlled with topical prescription therapies or when...
Renal Impairment:Adjust the starting dose of REVLIMID based on the creatinine clearance value and for patients on dialysis. Please see fullPrescribing Information, including Boxed WARNINGS, for REVLIMID.
Please click forFull Prescribing Information. References: ENTYVIO (vedolizumab) prescribing information. Takeda Pharmaceuticals. Briskin M, Winsor-Hines D, Shyjan A, et al. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue.Am...
followed by adding 1/1000 polybrene to enhance infection. The sequence of the HCP5-132aa shRNA is shown inTable S1. Lentivirus vector LV5 containing empty vector, full-length HCP5-132aa ORF or HCP5-132aa ORF-mut (lncRNA HCP5 with HCP5-132aa ORF start codon mutated to ATT) were pur...
Picture-in-PictureFullscreen Prolia® is an antiresorptive RANK Ligand inhibitor, and its mechanism of action makes it different than a bisphosphonate.1-7 Mechanism of action differences are not meant to imply clinical efficacy. As an essential mediator of osteoclast activity, increased RANK Ligand...